Study Name: An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
15 locations found
- GSK Investigational Site
Location: Portland, Oregon
- GSK Investigational Site
Location: Athens, Georgia 30607
- GSK Investigational Site
Location: Boston, Massachusetts 02215
- GSK Investigational Site
Location: Lebanon, New Hampshire 03756
- GSK Investigational Site
Location: Durham, North Carolina 27710
- GSK Investigational Site
Location: Columbus, Ohio 43210
- GSK Investigational Site
Location: Philadelphia, Pennsylvania 19104
- GSK Investigational Site
Location: Memphis, Tennessee 38120
- GSK Investigational Site
Location: Aurora, Colorado 80045
- GSK Investigational Site
Location: Coeur d'Alene, Idaho 83814
- GSK Investigational Site
Location: Indianapolis, Indiana 46202
- GSK Investigational Site
Location: Detroit, Michigan 48201
- GSK Investigational Site
Location: Minneapolis, Minnesota 55404
- GSK Investigational Site
Location: Houston, Texas 77030
- GSK Investigational Site
Location: Vancouver, Washington 98684
|